Treatment of NAFLD with N-Acetylsyctein, Pioglitazon and Metformi
Phase 3
- Conditions
- on Alcoholic Fatty Liver Disease.Nonalcoholic steatohepatitis
- Registration Number
- IRCT201309188308N3
- Lead Sponsor
- Vice Chancellor for Research and Technology University of Medical Sciences of Hamedan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1) Elevated liver enzymes > 1.5 times
2) Sonographic diagnosis of NAFLD (Grade 1 and more)
Exclusion criteria:
1) Viral hepatitis
2) Alcoholic liver disease
3) Autoimmune liver disease
4) Hepatotoxic drug use in the past 6 month
5) Systemic illness
6) Metabolic liver disease
7) Active drug abuse
8) Pregnancy
9) Diabetes mellitus
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver enzymes. Timepoint: two month. Method of measurement: Labratory.
- Secondary Outcome Measures
Name Time Method Grading of Steatosis. Timepoint: two month. Method of measurement: Sonography.